Tenax Therapeutics is trading 5.1% up at $1.87, with no clear company-specific catalyst identified for the move.
- The latest company announcement was a September 1 notice about a scheduled September 9 Cantor Global Healthcare Conference presentation.
- That presentation does not directly explain the September 4 increase.
- Broader markets were lower, so the advance does not clearly track overall market direction.